Physician Wealth Advisors’s T. Rowe Price TROW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8K Buy
174
+97
+126% +$9.92K ﹤0.01% 667
2026
Q1
$6.94K Buy
77
+9
+13% +$872 ﹤0.01% 905
2025
Q4
$6.96K Sell
68
-12
-15% -$1.24K ﹤0.01% 875
2025
Q3
$8.21K Buy
+80
New +$8.41K ﹤0.01% 802
2025
Q2
Sell
-27
Closed -$2.48K 1976
2025
Q1
$2.48K Buy
+27
New +$2.85K ﹤0.01% 833

Other funds holding TROW

Physician Wealth Advisors's TROW Position: Q2 2026 in Review

Physician Wealth Advisors increased its T. Rowe Price (TROW) stake by 126% in Q2 2026, buying an estimated $9.92K and bringing the position to 174 shares worth $19.8K. The position accounts for ﹤0.01% of the portfolio, ranked #667.

Physician Wealth Advisors first reported a position in TROW in Q1 2025 and has held it in 5 quarters since. 1,164 funds tracked by Wall St. Rank hold TROW as of Q2 2026.

  • Physician Wealth Advisors held 174 shares of T. Rowe Price worth $19.8K as of Q2 2026.
  • Physician Wealth Advisors bought 97 T. Rowe Price shares in Q2 2026, an estimated $9.92K.
  • T. Rowe Price made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #667 holding.
  • Physician Wealth Advisors first reported a position in T. Rowe Price in Q1 2025 and has held it in 5 quarters since.
  • 1,164 funds tracked by Wall St. Rank held T. Rowe Price as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.